This news is delayed by 15 minutes, sign up now to get live news & full features.
CELC CELCUITY INC
+ add to watchlist
$105.25
celcuity is a biotech company developing state-of-the-art cell-based assays using our proprietary functional cellular analysis platform. we directly assess the functionality of the disease-related signaling pathways of a patient's diseased cells ex vivo to determine whether a drug therapy has the intended effect on those cells. the patient specific cellular data we provide offers clinicians and pharmaceutical companies unique insight into a patient's response to a drug therapy, and it will change the paradigm of personalized medicine.
Mkt Cap: $4.87B
52 Week High: $112.64
P/E: 0.00
52 Week Low: $7.58
Dividend: $0.00
Shares Outstanding: 46.27M